CelLBxHealth plc Stock
Stocks
CLBX
GB0034330679
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
London S.E.
11:35:04 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 1.250 GBX | -5.66% |
|
-5.66% | +13.64% |
| Market Cap | 14.21M 19.36M 16.58M 15.52M 26.66M 1.85B 27.01M 183M 71.5M 931M 72.7M 71.12M 3.08B | P/E 2026 * |
-0.54x | P/E 2027 * | -13.9x |
|---|---|---|---|---|---|
| Enterprise Value | 12.61M 17.18M 14.72M 13.77M 23.66M 1.64B 23.97M 163M 63.44M 826M 64.51M 63.11M 2.73B | EV / Sales 2026 * |
0.58x | EV / Sales 2027 * | 0.41x |
| Free-Float |
95.3% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: CelLBxHealth plc
| 25-10-16 | Angle names Peter Collins as interim CEO | AN |
| 25-05-28 | RBC cuts National Grid; Citigroup cuts South32 | AN |
| 25-01-23 | HSBC raises FirstGroup, Goldman cuts Ithaca | AN |
| 23-09-14 | JPMorgan ups Rio Tinto; Redburn likes Carnival | AN |
| 22-01-24 | Berenberg Initiates Angle With Buy Rating, Sets PT | MT |
| 1 day | -5.66% | ||
| 1 week | -5.66% | ||
| Current month | -1.96% | ||
| 1 month | -1.96% | ||
| 3 months | -10.71% | ||
| 6 months | +19.05% | ||
| Current year | +13.64% |
| 1 week | 1.21 |  | 1.36 |
| 1 month | 1.2 | | 1.4 |
| Current year | 0.85 | | 2.8 |
| 1 year | 0.85 | | 8 |
| 3 years | 0.85 | | 37.4 |
| 5 years | 0.85 | | 163.75 |
| 10 years | 0.85 | | 163.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sinéad Armstrong
DFI | Director of Finance/CFO | - | 1998-12-31 |
| Chief Tech/Sci/R&D Officer | - | 2024-12-31 | |
Karen Miller
CTO | Chief Tech/Sci/R&D Officer | - | 2023-06-04 |
| Director | Title | Age | Since |
|---|---|---|---|
Jan Groen
CHM | Chairman | 67 | 2023-05-21 |
Klaas de Boer
BRD | Director/Board Member | 61 | 2026-01-11 |
| Director/Board Member | 61 | 2026-01-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/19/25 | Buy | Chief Executive Officer | 5,000,000 | 1.5497% | ||
| 12/19/25 | Buy | Chief Financial Officer | 2,500,000 | 0.7749% | ||
| 12/19/25 | Buy | Chairman | 5,000,000 | 1.5497% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.66% | -5.66% | -80.00% | -89.36% | 19.36M | |
| -0.84% | +3.92% | +28.04% | -29.04% | 17.87B | |
| -3.05% | -7.40% | -38.72% | +93.72% | 1.64B | |
| -0.74% | +3.08% | -42.56% | -80.75% | 1.01B | |
| +1.26% | +0.44% | -21.55% | +28.94% | 997M | |
| +0.11% | +0.11% | +63.23% | -6.33% | 780M | |
| -2.29% | -1.45% | -36.91% | -46.86% | 689M | |
| -1.91% | -12.67% | -44.02% | -44.74% | 566M | |
| +3.23% | +2.36% | -39.55% | -34.64% | 457M | |
| +3.19% | +6.69% | +77.41% | +50.00% | 441M | |
| Average | -0.67% | -1.30% | -13.46% | -15.91% | 2.45B | |
| Weighted average by Cap. | -0.79% | +2.22% | +15.81% | -19.47% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.65M 29.51M 25.28M 23.65M 40.63M 2.82B 41.17M 279M 109M 1.42B 111M 108M 4.69B | 37.75M 51.45M 44.07M 41.24M 70.85M 4.92B 71.78M 487M 190M 2.47B 193M 189M 8.18B |
| Net income | -8.55M -11.65M -9.98M -9.34M -16.05M -1.12B -16.26M -110M -43.03M -560M -43.76M -42.81M -1.85B | -1.85M -2.52M -2.16M -2.02M -3.47M -241M -3.52M -23.88M -9.31M -121M -9.47M -9.26M -401M |
| Net Debt | -1.6M -2.18M -1.87M -1.75M -3M -209M -3.04M -20.65M -8.05M -105M -8.19M -8.01M -347M | 1.4M 1.91M 1.63M 1.53M 2.63M 183M 2.66M 18.07M 7.05M 91.72M 7.17M 7.01M 303M |
Employees
114
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-21 | GBX 1.250 | -5.66% | 2,521,803 |
| 26-08-20 | GBX 1.325 | 0.00% | 1,164,610 |
| 26-08-19 | GBX 1.325 | 0.00% | 269,135 |
| 26-08-18 | GBX 1.325 | 0.00% | 1,708,305 |
| 26-08-17 | GBX 1.325 | 0.00% | 245,049 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0125GBP
Average target price
0.0400GBP
Spread / Average Target
+220.00%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- CLBX Stock
Select your edition
All financial news and data tailored to specific country editions
